Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,209 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Completed

Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma

NCT01721772

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Fundacion Cidea Buenos Aires, Distrito Federal, Argentina
  • Instituto Medico Especialazado Alexander Fleming Buenos Aires, Argentina
  • Instituto Oncologico De Cordoba Córdoba, Argentina
  • Local Institution Camperdown, New South Wales, Australia
View all 75 locations
View Trial Details
Completed

PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma

NCT00073892

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +11 more
Locations
  • University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora, Colorado, United States
  • Princess Alexandra Hospital Brisbane, Queensland, Australia
  • Queen Elizabeth Hospital Woodville, South Australia, Australia
  • Alfred Hospital Melbourne, Victoria, Australia
View Trial Details
Completed

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

NCT02714218

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University Of Colorado Cancer Center Aurora, Colorado, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Allina Health Fridley, Minnesota, United States
  • Washington University School Of Medicine St Louis, Missouri, United States
View all 57 locations
View Trial Details
Completed

Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma

NCT00130442

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Arizona Cancer Centre Tucson, Arizona, United States
  • University of Colorado Health Science Centre Denver, Colorado, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • Sydney Cancer Centre, Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
View Trial Details

Related conditions